Cozad Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $867K | Buy |
35,997
+833
| +2% | +$21.8K | 0.06% | 249 |
|
|
2026
Q1 | $987K | Sell |
35,164
-38
| -0.1% | -$1.01K | 0.08% | 224 |
|
|
2025
Q4 | $877K | Sell |
35,202
-929
| -3% | -$23.4K | 0.07% | 235 |
|
|
2025
Q3 | $921K | Sell |
36,131
-1,955
| -5% | -$48.3K | 0.07% | 223 |
|
|
2025
Q2 | $923K | Buy |
38,086
+1,509
| +4% | +$35.2K | 0.08% | 212 |
|
|
2025
Q1 | $927K | Buy |
36,577
+2,153
| +6% | +$56.3K | 0.09% | 201 |
|
|
2024
Q4 | $913K | Sell |
34,424
-9,660
| -22% | -$262K | 0.09% | 199 |
|
|
2024
Q3 | $1.28M | Sell |
44,084
-333
| -0.7% | -$9.71K | 0.12% | 169 |
|
|
2024
Q2 | $1.24M | Buy |
44,417
+580
| +1% | +$16K | 0.12% | 169 |
|
|
2024
Q1 | $1.22M | Buy |
43,837
+5,005
| +13% | +$139K | 0.13% | 172 |
|
|
2023
Q4 | $1.12M | Sell |
38,832
-1,747
| -4% | -$52.8K | 0.13% | 168 |
|
|
2023
Q3 | $1.35M | Buy |
40,579
+1,228
| +3% | +$43.4K | 0.17% | 138 |
|
|
2023
Q2 | $1.44M | Sell |
39,351
-4,104
| -9% | -$160K | 0.18% | 142 |
|
|
2023
Q1 | $1.77M | Sell |
43,455
-35,343
| -45% | -$1.53M | 0.23% | 118 |
|
|
2022
Q4 | $4.04M | Buy |
78,798
+7,880
| +11% | +$378K | 0.57% | 47 |
|
|
2022
Q3 | $3.1M | Sell |
70,918
-4,391
| -6% | -$213K | 0.5% | 53 |
|
|
2022
Q2 | $3.95M | Buy |
75,309
+797
| +1% | +$40.6K | 0.62% | 42 |
|
|
2022
Q1 | $3.86M | Buy |
74,512
+8,094
| +12% | +$420K | 0.54% | 51 |
|
|
2021
Q4 | $3.92M | Buy |
66,418
+335
| +0.5% | +$16.6K | 0.56% | 48 |
|
|
2021
Q3 | $2.84M | Buy |
66,083
+320
| +0.5% | +$14.2K | 0.44% | 60 |
|
|
2021
Q2 | $2.58M | Sell |
65,763
-4,813
| -7% | -$187K | 0.4% | 66 |
|
|
2021
Q1 | $2.56M | Buy |
70,576
+3,619
| +5% | +$128K | 0.42% | 64 |
|
|
2020
Q4 | $2.46M | Sell |
66,957
-11,730
| -15% | -$430K | 0.44% | 61 |
|
|
2020
Q3 | $2.74M | Sell |
78,687
-5,555
| -7% | -$195K | 0.52% | 53 |
|
|
2020
Q2 | $2.61M | Sell |
84,242
-588
| -0.7% | -$20K | 0.53% | 52 |
|
|
2020
Q1 | $2.63M | Sell |
84,830
-3,027
| -3% | -$103K | 0.91% | 29 |
|
|
2019
Q4 | $3.27M | Sell |
87,857
-498
| -0.6% | -$17.7K | 0.87% | 28 |
|
|
2019
Q3 | $3.01M | Sell |
88,355
-238
| -0.3% | -$8.65K | 0.87% | 32 |
|
|
2019
Q2 | $3.64M | Sell |
88,593
-685
| -0.8% | -$27.2K | 1.05% | 27 |
|
|
2019
Q1 | $3.6M | Sell |
89,278
-134
| -0.1% | -$5.37K | 1.09% | 25 |
|
|
2018
Q4 | $3.7M | Buy |
89,412
+3,458
| +4% | +$144K | 1.28% | 19 |
|
|
2018
Q3 | $3.59M | Sell |
85,954
-1,077
| -1% | -$41.5K | 1.05% | 23 |
|
|
2018
Q2 | $3M | Buy |
+87,031
| New | +$2.97M | 0.93% | 27 |
|
Other funds holding PFE
Cozad Asset Management's PFE Position: Q2 2026 in Review
Cozad Asset Management increased its Pfizer (PFE) stake by 2.4% in Q2 2026, buying an estimated $21.8K and bringing the position to 35,997 shares worth $867K. The position accounts for 0.06% of the portfolio, ranked #249.
Cozad Asset Management first reported a position in PFE in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.04M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cozad Asset Management held 35,997 shares of Pfizer worth $867K as of Q2 2026.
- Cozad Asset Management bought 833 Pfizer shares in Q2 2026, an estimated $21.8K.
- Pfizer made up 0.06% of Cozad Asset Management's portfolio in Q2 2026, its #249 holding.
- Cozad Asset Management first reported a position in Pfizer in Q2 2018 and has held it in 33 quarters since.
- Cozad Asset Management's Pfizer position peaked at $4.04M in Q4 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cozad Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.